Advanced Search
LU Jingning, YANG Hong, PENG Minhao, XIAO Kaiyin, PENG Tao, PENG Jinbo. Percutaneous Ultrasound-guided Radiofrequency Ablation with Artificial Ascites for Hepatocellular Carcinoma in Hepatic Dome[J]. Cancer Research on Prevention and Treatment, 2015, 42(05): 493-497. DOI: 10.3971/j.issn.1000-8578.2015.05.016
Citation: LU Jingning, YANG Hong, PENG Minhao, XIAO Kaiyin, PENG Tao, PENG Jinbo. Percutaneous Ultrasound-guided Radiofrequency Ablation with Artificial Ascites for Hepatocellular Carcinoma in Hepatic Dome[J]. Cancer Research on Prevention and Treatment, 2015, 42(05): 493-497. DOI: 10.3971/j.issn.1000-8578.2015.05.016
shu

Percutaneous Ultrasound-guided Radiofrequency Ablation with Artificial Ascites for Hepatocellular Carcinoma in Hepatic Dome

  • 1. Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China; 2. Department of Ultrasound, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China

More Information
  • Received Date: November 19, 2014
  • Revised Date: December 18, 2014
    Graphical Abstract
    • Abstract
  • Objective To investigate the feasibility, efficacy, and safety of percutaneous ultrasound-guided radiofrequency ablation(RFA) with artificial ascites for hepatocellular carcinoma(HCC) in the hepatic dome. Methods We retrospectively analyzed the clinical data of 22 patients with HCC in the hepatic dome with 25 lesions underwent percutaneous ultrasound-guided RFA with artificial ascites from January 2010 to December 2012. We used Seldinger technique to artificially induce ascites before RFA to improve tumor visibility or electrode path and to separate the RFA zone from the diaphragm. We assessed the technical feasibility, safety and efficacy of this technique in clinic. Results RFA was successfully performed in 88.0% (22/25) lesions after artificial ascites was achieved. There was substantial improvement in the visibility of partially visible tumors and in achieving a better path of the tumors with a poor electrode path. All patients showed complete absorption of artificial ascites after 3-day follow-up ultrasound. There was no patient showed any serious complications such as hemoperitoneum, peritonitis, hemothorax or pneumothorax. All tumors were completed ablation and there was no residual tumor after 1-month follow-up by CECT/MRI. Conclusion Establishment of artificial ascites could make HCC in the hepatic dome clearly displayed by ultrasound and broaden the indications of percutaneous RFA treatment. Percutaneous RFA with artificial ascites appears to be a feasible, safe and effective technique for treating HCC in the hepatic dome.
    • FullText(HTML)
    • References (20)
  • [1]
    Kudo M. Radiofrequency ablation for hepatocellular carcinoma: updated review in 2010[J]. Oncology, 2010, 78 Suppl 1: 113-24.
    [2]
    Bruix J, Sherman M. Management of hepatocellular carcinoma: an update[J]. Hepatology, 2011, 53(3): 1020-2.
    [3]
    Luo DY, Xu GL, Jia WD, et al. Surgical treatment of hepatocellular carcinoma with portal hypertension[J]. Zhong Liu Fang Zhi Yan Jiu, 2014, 41(8): 925-7. [罗大勇, 许戈良, 荚卫东, 等. 肝细胞性肝癌合并静脉高压症的外科治疗[J]. 肿瘤防治研 究, 2014, 41(8): 925-7.]
    [4]
    Kang TW, Rhim H, Lee MW, et al. Radiofrequency ablation for hepatocellular carcinoma abutting the diaphragm: comparison of effects of thermal protection and therapeutic efficacy[J]. AJR Am J Roentgenol, 2011, 196(4): 907-13.
    [5]
    Kim YS, Lim HK, Rhim H, et al. Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors[J]. J Hepatol, 2013, 58(1): 89-97.
    [6]
    O’Neill MJ, Weissleder R, Gervais DA, et al. Tunneled peritoneal catheter placement under sonographic and fluoroscopicguidance in the palliative treatment of malignant ascites[J]. AJR Am J Roentgenol, 2001, 177(3): 615-8.
    [7]
    Rhim H, Lim HK, Kim YS, et al. Percutaneous radiofrequency ablation with artificial ascites for hepatocellularcarcinoma in the hepatic dome: initial experience[J]. AJR Am J Roentgenol, 2008, 19 0(1): 91-8.
    [8]
    Akinci D, Erol B, Ciftci TT, et al. Radiologically placed tunneled peritoneal catheter in palliation of malignantascites[J]. Eur J Radiol, 2011, 80(2): 265-8.
    [9]
    Laeseke PF, Sampson LA, Brace CL, et al. Unintended thermal injuries from radiofrequency ablation: protection with 5% dextrose in water[J]. AJR Am J Roentgenol, 2006, 186(5 Suppl): S249-54.
    [10]
    Kei SK, Rhim H, Choi D, et al. Local tumor progression after radiofrequency ablation of liver tumors: analysis of morphologic pattern and site of recurrence[J]. AJR Am J Roentgenol, 2008, 19 0(6): 1544-51.
    [11]
    Chopra S, Dodd GD 3rd, Chintapalli KN, et al. Tumor recurrence after radiofrequency thermal ablation of hepatic tumors: spectrum of findings on dual-phase contrast-enhanced CT[J]. AJR Am J Roentgenol, 2001, 177(2): 381-7.
    [12]
    DuBay DA, Sandroussi C, Kachura JR, et al. Radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation[J]. HPB (Oxford), 2011, 13(1): 24-32.
    [13]
    Schroeder T, Sotiropoulos GC, Molmenti EP, et al. Changes in staging for hepatocellular carcinoma after radiofrequency ablation prior to liver transplantation as found in the explanted liver[J]. Hepatogastroenterology, 2011, 58(112): 2029-31.
    [14]
    Fukuno H, Tamaki K, Urata M, et al. Influence of an artificial pleural effusion technique on cardio-pulmonary function and autonomic activity[J]. J Med Invest, 2007, 54(1-2): 48-53.
    [15]
    Iwai S, Sakaguchi H, Fujii H, et al. Benefits of artificially induced pleural effusion and/or ascites for percutaneous radiofrequency ablation of hepatocellular carcinoma located on the liver surface and in the hepatic dome[J]. Hepatogastroenterology, 2012, 59 (114): 546-50.
    [16]
    Liu LN, Xu HX, Lv MD. Percutaneous ultrasound-guided ablation for liver tumor with artificial pleural effusion[J]. Zhonghua Yi Xue Chao Sheng Za Zhi (Dian Zi Ban), 2012, 9(12): 1034-9. [刘琳娜, 徐辉雄, 吕明德. 人工胸腔积液在超声引导经皮消融肝肿瘤中 的应用[J]. 中华医学超声杂志(电子版), 2012, 9(12): 1034-9.]
    [17]
    Zhang D, Liang P, Yu X, et al. The value of artificial pleural effusion for percutaneous microwave ablation of liver tumour in the hepatic dome: a retrospective case-control study[J]. Int J Hyperthermia, 2013, 29(7): 663-70.
    [18]
    Koda M, Ueki M, Maeda Y, et al. Percutaneous sonographically guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma located under the diaphragm[J]. AJR Am J Roentgenol, 2004, 183(3): 583-8.
    [19]
    Nishimura M, Nouso K, Kariyama K, et al. Safety and efficacy of radiofrequency ablation with artificial ascites for hepatocellular carcinoma[J]. Acta Med Okayama, 2012, 66(3): 279-84.
    [20]
    Rhim H, Lim HK. Radiofrequency ablation for hepatocellular carcinoma abutting the diaphragm: the value of artificial ascites[J]. Abdom Imaging, 2009, 34(3): 371-80.
    • Related Articles

Catalog

    Get Citation
    PDF
    XML
    Article views (1997) PDF downloads (66579) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References

    Download Center

    Links

    Contact Us

    Address：116 Zhuodaoquan South Road,
    Hongshan District, Wuhan（430079）

    Tel：027－87670126

    Email：zlfzyjzz@vip.163.com

    This work is licensed under a Creative Commons Attribution 3.0 License.

    Email Alert RSS
    Total visits：19053395 Visits today：27288

    Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return